|
ABOUT COMPANY
Karyopharm Therapeutics Inc., a pharmaceutical company, is dedicated to the discovery, development and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is headquartered in Newton, Massachusetts.
|
EARNINGS
Gross Profit (TTM): -45433000
Market Capitalization: 536387000
Operating Margin (TTM): -1.536
PE Ratio: None
PEG Ratio: -0.15
Profit Margin: -1.738
Revenue Per Share (TTM): 1.588
Revenue (TTM): 118650000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.767
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -2.76
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -212348000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|